Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

ADCT holding history

ADC Therapeutics SA in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings

Shares (Q4 2021)
0
Sold out in Q4 2021
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2021
Holdings of ADCT by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20210$00.0%−72,000−100.0%Sold outHolders
Q3 202172,000$1.96M0.1%−10,900−13.1%ReducedHolders
Q2 202182,900$2.02M0.1%+26,900+48.0%AddedHolders
Q1 202156,000$1.37M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.